Skip to main content

Table 1 Weighted averages of HIV drug resistance EWI performance from 35 HIV care and treatment facilities, aggregated by programmatic characteristics, Tanzania, 2010

From: Monitoring prevention or emergence of HIV drug resistance: results of a population-based foundational survey of early warning indicators in mainland Tanzania

Programmatic characteristics

HIVDR early warning indicators (EWIs)

   

EWI 1a, ART prescription practices

EWI 2, patients LTFU at 12 months

EWI 3a, retention on 1st line ART at 12 months

EWI 5b, clinic appointment keeping in first 12 months

   

WHO target: 100%

WHO target: ≤ 20%

WHO target: ≥ 70%

WHO target: ≥ 80%

 

Facility counts n (%)

Total # initiated on ART in 2010

%

% (95% CI)

% (95% CI)

% (95% CI)

National average performance on EWIs

35 (100)

13,466

100

26 (25–26)

54 (53–54)

38 (37–38)

Facility administrative level

Referral hospitals

4 (11)

2346

100

25 (24–26)

53 (52–55)

54 (53–55)

Non-referral hospitals

17 (49)

8512

100

22 (21–23)

56 (55–56)

37 (36–37)

Health centers

14 (40)

2608

100

32 (30–33)

51 (49–52)

31 (30–32)

Facility geographical locality

Urban

20 (57)

11,604

100

22 (22–23)

56 (55–56)

40 (40–41)

Semi-urban

6 (17)

601

100

43 (41–46)

39 (37–41)

29 (28–30)

Rural

9 (26)

1261

100

27 (26–28)

55 (54–56)

33 (32–34)

Facility ownership

Public

28 (80)

9661

100

24 (23–25)

54 (53–55)

34 (33–34)

Faith-based

7 (20)

3805

100

30 (29–31)

53 (52–54)

50 (49–51)

Facility maturity (years providing ART services)

> 5

6 (17)

4684

100

18 (17–19)

61 (60–62)

47 (46–48)

3-5

15 (43)

6174

100

25 (24–26)

52 (51–53)

37 (37–38)

< 3

14 (40)

2608

100

32 (30–33)

51 (49–52)

31 (30–32)

Median: 4 years IQR: 2–5 years

 
  1. IQR interquartile range.
  2. EWI 1a, % of adult patients initiating ART at the site who are initially prescribed, or who initially pick up from the pharmacy, an appropriate first-line ART regimen.
  3. EWI 2, % of patients initiating ART at the site who are lost to follow-up (LTFU) 12 months after ART initiation.
  4. EWI 3a, % of adult patients initiating ART at the site who are taking an appropriate first-line ART regimen 12 months later.
  5. EWI 5b, % of patients initiating ART at the site who attended all scheduled or expected clinical consultations on time during the first 12 months.